FOXO1 Inhibitors
FOXO1 inhibitors represent a class of chemical compounds that specifically target and inhibit the activity of the transcription factor FOXO1 (Forkhead box O1). FOXO1 is a member of the Forkhead family of transcription factors, characterized by a conserved DNA-binding domain known as the Forkhead box, which allows them to regulate the expression of genes involved in various cellular processes. FOXO1 is a key regulator of cellular homeostasis, modulating functions like cell cycle progression, apoptosis, metabolism, and oxidative stress responses. FOXO1 activity is tightly controlled by post-translational modifications, including phosphorylation, acetylation, and ubiquitination. Inhibitors of FOXO1 act by interfering with its ability to bind to DNA or by altering its localization and degradation, thus preventing it from exerting its regulatory effects on target genes.
Structurally, FOXO1 inhibitors can belong to various chemical families, ranging from small molecules to peptides. These inhibitors often possess structural motifs that enable them to bind to the FOXO1 protein or disrupt its interactions with other molecules involved in transcriptional regulation. Inhibition of FOXO1 can result from blocking its nuclear localization or enhancing its degradation, which leads to decreased transcriptional activity. The design and synthesis of FOXO1 inhibitors often involve a detailed understanding of the transcription factor's structure, particularly its DNA-binding domain, to achieve high specificity and potency. Various assays, such as reporter gene assays or protein-DNA interaction studies, are typically employed to assess the inhibitory efficacy of these compounds in disrupting FOXO1-mediated transcriptional activities.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AS 1842856 | 836620-48-5 | sc-507096 sc-507096A | 10 mg 50 mg | $99.00 $415.00 | ||
AS 1842856 may downregulate FOXO1 by impeding the protein's translocation into the nucleus, preventing it from binding to DNA to control gene transcription, which is essential for its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could decrease FOXO1 expression by inhibiting histone deacetylases, thus altering the acetylation status of histones, which can lead to a closed chromatin conformation that is less permissive for the transcription of the FOXO1 gene. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 may decrease FOXO1 expression by inhibiting the phosphoinositide 3-kinases (PI3K), thereby reducing Akt kinase activity, which would otherwise phosphorylate and inactivate FOXO1, leading to its retention in the cytoplasm and subsequent degradation. | ||||||
WYE-125132 | 1144068-46-1 | sc-364651 sc-364651A | 10 mg 50 mg | $510.00 $1536.00 | ||
WYE-125132 could inhibit FOXO1 expression by targeting the PI3K/Akt/mTOR signaling cascade, promoting phosphorylation and inactivation of FOXO1 by Akt, which results in FOXO1's sequestration away from the nucleus. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Spautin-1 may lead to a reduction in FOXO1 expression by promoting the degradation of PI3K, which is upstream of Akt signaling. Reduced Akt activity results in less phosphorylation and inactivation of FOXO1, possibly initiating a negative feedback loop that diminishes FOXO1 gene expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may attenuate FOXO1 expression by inhibiting the kinase activity of Akt, which is crucial for the phosphorylation and subsequent inactivation of FOXO1. This inhibition can lead to enhanced nuclear localization and transcriptional activation of FOXO1, potentially triggering mechanisms that reduce its gene expression. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol may indirectly contribute to the reduction of FOXO1 expression by causing cell cycle arrest, which could disrupt normal cell cycle-dependent transcription dynamics of the FOXO1 gene. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose might reduce FOXO1 expression by mimicking glucose and interfering with glycolytic ATP production, which could lead to cellular stress responses that alter the transcriptional landscape, including that of FOXO1. | ||||||
Silybin | 22888-70-6 | sc-202812 sc-202812A sc-202812B sc-202812C | 1 g 5 g 10 g 50 g | $55.00 $114.00 $206.00 $714.00 | 6 | |
Silybin may inhibit FOXO1 expression by interacting with insulin/IGF-1 signaling components, leading to alterations in downstream transcription factors and gene expression profiles, including those of FOXO1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin has the potential to decrease FOXO1 expression by inhibiting mTOR, which is a central component of cell growth and proliferation signaling. This inhibition may create a shift in cellular resource allocation away from growth-related processes, including the transcription and translation of FOXO1. | ||||||